Circuit and Cell-Specific Contributions to Decision Making Involving Risk of Explicit Punishment in Male and Female Rats.
amygdala
dopamine
nucleus accumbens
punishment
risk taking
sex differences
Journal
The Journal of neuroscience : the official journal of the Society for Neuroscience
ISSN: 1529-2401
Titre abrégé: J Neurosci
Pays: United States
ID NLM: 8102140
Informations de publication
Date de publication:
28 06 2023
28 06 2023
Historique:
received:
03
02
2023
revised:
29
05
2023
accepted:
01
06
2023
pmc-release:
28
12
2023
medline:
30
6
2023
pubmed:
8
6
2023
entrez:
7
6
2023
Statut:
ppublish
Résumé
Decision making is a complex cognitive process that recruits a distributed network of brain regions, including the basolateral amygdala (BLA) and nucleus accumbens shell (NAcSh). Recent work suggests that communication between these structures, as well as activity of cells expressing dopamine (DA) D2 receptors (D2R) in the NAcSh, are necessary for some forms of decision making; however, the contributions of this circuit and cell population during decision making under risk of punishment are unknown. The current experiments addressed this question using circuit-specific and cell type-specific optogenetic approaches in rats during a decision making task involving risk of punishment. In experiment 1, Long-Evans rats received intra-BLA injections of halorhodopsin or mCherry (control) and in experiment 2, D2-Cre transgenic rats received intra-NAcSh injections of Cre-dependent halorhodopsin or mCherry. Optic fibers were implanted in the NAcSh in both experiments. Following training in the decision making task, BLA→NAcSh or D2R-expressing neurons were optogenetically inhibited during different phases of the decision process. Inhibition of the BLA→NAcSh during deliberation (the time between trial initiation and choice) increased preference for the large, risky reward (increased risk taking). Similarly, inhibition during delivery of the large, punished reward increased risk taking, but only in males. Inhibition of D2R-expressing neurons in the NAcSh during deliberation increased risk taking. In contrast, inhibition of these neurons during delivery of the small, safe reward decreased risk taking. These findings extend our knowledge of the neural dynamics of risk taking, revealing sex-dependent circuit recruitment and dissociable activity of selective cell populations during decision making.
Identifiants
pubmed: 37286352
pii: JNEUROSCI.0276-23.2023
doi: 10.1523/JNEUROSCI.0276-23.2023
pmc: PMC10312052
doi:
Substances chimiques
Halorhodopsins
0
Receptors, Dopamine D2
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4837-4855Subventions
Organisme : NIDA NIH HHS
ID : R03 DA050118
Pays : United States
Organisme : NIDA NIH HHS
ID : R00 DA041493
Pays : United States
Organisme : NIDA NIH HHS
ID : F31 DA057112
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA036534
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG060778
Pays : United States
Commentaires et corrections
Type : UpdateOf
Informations de copyright
Copyright © 2023 the authors.
Références
Transl Psychiatry. 2014 Aug 05;4:e422
pubmed: 25093600
Nature. 2011 Jun 29;475(7356):377-80
pubmed: 21716290
J Neurosci. 2023 Feb 15;43(7):1238-1255
pubmed: 36609453
Science. 2022 Jan 07;375(6576):eabg7277
pubmed: 34990249
Neuron. 2016 Jun 1;90(5):1100-13
pubmed: 27181061
Neurobiol Stress. 2022 May 06;18:100458
pubmed: 35586750
Behav Brain Res. 2017 Jan 15;317:122-131
pubmed: 27641323
Learn Mem. 2015 Jan 15;22(2):128-37
pubmed: 25593299
Elife. 2019 Apr 24;8:
pubmed: 31017572
Nature. 2016 Mar 31;531(7596):642-6
pubmed: 27007845
J Neurosci. 2017 Nov 1;37(44):10567-10586
pubmed: 28954870
Neurosci Biobehav Rev. 2015 Nov;58:147-67
pubmed: 26072028
Neurobiol Learn Mem. 2017 Mar;139:89-97
pubmed: 28065715
Drug Alcohol Depend. 2005 Feb 14;77(2):169-75
pubmed: 15664718
Biol Psychiatry. 2018 Dec 15;84(12):893-904
pubmed: 29921416
Neuropsychopharmacology. 2014 Mar;39(4):955-62
pubmed: 24145852
Proc Natl Acad Sci U S A. 2017 Oct 10;114(41):E8750-E8759
pubmed: 28973852
Cogn Affect Behav Neurosci. 2019 Jun;19(3):459-476
pubmed: 30341621
Cell Rep. 2019 Aug 27;28(9):2256-2263.e3
pubmed: 31461643
Neuropsychopharmacology. 2017 Jan;42(2):397-407
pubmed: 27577601
Neuropharmacology. 2018 Sep 1;139:205-216
pubmed: 30009836
Nat Commun. 2016 Jun 23;7:11829
pubmed: 27337658
Pharmacol Biochem Behav. 1975 Jan-Feb;3(1):47-55
pubmed: 1129354
Neuroscience. 1988 Aug;26(2):403-15
pubmed: 3173682
eNeuro. 2018 Dec 10;5(6):
pubmed: 30627636
J Neurosci. 2011 Nov 30;31(48):17460-70
pubmed: 22131407
J Neurosci. 2015 Feb 25;35(8):3470-7
pubmed: 25716846
Front Behav Neurosci. 2019 May 10;13:91
pubmed: 31133832
Brain Res. 1991 Jul 19;554(1-2):85-94
pubmed: 1681991
J Neurosci. 1987 Dec;7(12):3915-34
pubmed: 2891799
Curr Protoc Mol Biol. 2010 Oct;Chapter 14:Unit14.20
pubmed: 20890901
J Neurosci. 2017 Nov 29;37(48):11537-11548
pubmed: 29079687
Nat Neurosci. 2014 Sep;17(9):1198-207
pubmed: 25108911
Nat Commun. 2018 Feb 21;9(1):731
pubmed: 29467419
J Neurosci. 2016 Nov 30;36(48):12069-12079
pubmed: 27903717
eNeuro. 2018 May 16;5(2):
pubmed: 29780881
Neurobiol Learn Mem. 2017 Apr;140:92-105
pubmed: 28242266
Psychopharmacology (Berl). 2020 Jul;237(7):1893-1908
pubmed: 32363438
Mol Psychiatry. 2022 Jan;27(1):669-686
pubmed: 33963288
Biol Mood Anxiety Disord. 2012 Apr 16;2:7
pubmed: 22738021
Neuropsychopharmacology. 2009 Feb;34(3):681-97
pubmed: 18668030
Sci Rep. 2019 Aug 23;9(1):12292
pubmed: 31444385
Neuropsychopharmacology. 2022 May;47(6):1199-1209
pubmed: 34493829
Neuropsychologia. 2002;40(10):1675-89
pubmed: 11992656